The Exchange was notified by DITO CME Holdings Corp. (“DITO” or the “Company”) that its “management has determined that current market conditions are less than ideal to pursue the offering” and that “upon careful consideration of its business strategies, DITO CME has decided to defer the Stock Rights Offer.” In the same letter, DITO said that “[it] shall refund any and all subscription payments made by any existing shareholder or qualified institutional buyer during the offer period of the Stock Rights Offer.”
THIS SHOULD NOT BE CONSTRUED AS AN APPROVAL BY THE EXCHANGE OF THE DEFERMENT OF THE OFFERING. FURTHERMORE, THIS IS WITHOUT PREJUDICE TO ANY REGULATORY ACTION THAT THE EXCHANGE MAY PURSUE IN ORDER TO ENSURE FULL COMPLIANCE WITH THE APPLICABLE RULES AND FOR THE PROTECTION OF THE INVESTING PUBLIC CONSISTENT WITH THE MANDATE OF THE EXCHANGE, AS A SELF-REGULATORY ORGANIZATION, TO MAINTAIN A FAIR AND ORDERLY MARKET.
THE POSTING OF THIS NOTICE IS STRICTLY FOR DISSEMINATION PURPOSES ONLY. THE COMPANY, ITS UNDERWRITER, AND OTHER ADVISERS ARE RESPONSIBLE FOR STRICT COMPLIANCE WITH THE RULES OF THE EXCHANGE.
THE EXCHANGE DISCLAIMS ANY LIABILITY ARISING FROM, OR IN CONNECTION WITH, THE FOREGOING MATTER.
For your information and guidance. |
NOTICE